COMPANY
Enigma Biomedical
Funding and NIH signals
- NIH award NIH awarded $897K (SBIR Phase II 1R44AG102186-01, new, notice Sep 17, 2026). NIH RePORTER 1R44AG102186-01 (Sep 17, 2026)
Evidence (1 event)
- Sep 17, 2026 · NIH RePORTER 1R44AG102186-01
Organization: ENIGMA BIOMEDICAL USA, INC; City/State: KNOXVILLE, TN; Project number: 1R44AG102186-01; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-09-17; FY total cost (award amount): 896719; Administering IC: National Institute on Aging; Project title: Clinical Evaluation of a Novel [18F] Positron Emission Tomography (PET) Tracer for Differential Diagnosis and Staging of 4R Tauopathies; Organization type: Domestic For-Profits
- Sep 17, 2026 · NIH RePORTER 1R44AG102186-01
Timeline
- Partnership Partnership / licensing announced Feb 20, 2026. Source: company's own press page. source ↗
Funding
- Partnership / licensing announced Feb 20, 2026. Source: company's own press page. source ↗